Anthem Biosciences Ltd

Anthem Biosciences Q2 FY27 Results: Net Profit ₹211.5 Cr, Up 22.0% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹594 Cr (+7.9% YoY) and net profit of ₹211.5 Cr (+22.0% YoY) for Q2 FY27.

Key figure

Net profit ₹211.5 Cr · +22.0% YoY

Anthem Biosciences Q1 FY27 Results: Net Profit ₹119.9 Cr, Down 11.7% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹418.2 Cr (-22.6% YoY) and net profit of ₹119.9 Cr (-11.7% YoY) for Q1 FY27.

Key figure

Net profit ₹119.9 Cr · -11.7% YoY

Anthem Biosciences Q4 FY26 Results: Net Profit ₹189.8 Cr, Up 129.8% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹610.9 Cr (+26.4% YoY) and net profit of ₹189.8 Cr (+129.8% YoY) for Q4 FY26.

Key figure

Net profit ₹189.8 Cr · +129.8% YoY

Anthem Biosciences Financial Results

Anthem Biosciences Limited approved its audited annual financial results for fiscal year 2026. The Board also recommended a final dividend of ₹2.00 per share.